Clínica Médica

M-A | Miopericardite após vacinação contra COVID-19 e vacinação não relacionada a COVID-19.

19 Abr, 2022 | 12:41h

Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis – The Lancet Respiratory Medicine

Comentários:

Myopericarditis following COVID-19 vaccination is rare, finds international study – The Lancet

Myopericarditis after COVID-19 vaccination: unexpected but not unprecedented – The Lancet Respiratory Medicine

Study explores myopericarditis incidence and COVID-19 vaccination – News Medical

 

Comentário no Twitter

NEW—Myopericarditis following #COVID19 vaccination is rare, finds international study published in @LancetRespirMed: https://t.co/d3ZRvTWrGB pic.twitter.com/6sHiRyEbTk

— The Lancet (@TheLancet) April 11, 2022

 

---

Diretrizes para o monitoramento terapêutico medicamentoso da vancomicina.

19 Abr, 2022 | 12:37h

Clinical Practice Guidelines for Therapeutic Drug Monitoring of Vancomycin in the Framework of Model-Informed Precision Dosing: A Consensus Review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring – Pharmaceutics

Diretriz relacionada:

Diretriz: Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists

Resumo: Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists – Clinical Infectious Diseases

 

Comentário no Twitter

🔔Rings Cowbell🔔
New Vancomycin guidelines drop from Japan.

This is the most written about the need for #PrecisionDosing that I have seen.

Give patients the dose they need because #OneSizeFitsNone@SIDPharm @ABsteward @IDstewardship https://t.co/wlwgkqZmXu

— Marc H. Scheetz (@IDPharmacometrx) April 13, 2022

 

---

Estudo de coorte multicêntrico | Diarreia durante doença crítica.

19 Abr, 2022 | 12:35h

Diarrhea during critical illness: a multicenter cohort study – Intensive Care Medicine

 

Comentário no Twitter

Diarrhea in #ICU
➡️common but variable incidence (definition applied)
➡️rarely caused by Clostridioides difficile
➡️modifiable predictors include EN/duration of ABs exposure
➡️associated with longer time to discharge but not increased mortality#FOAMcc
📖 https://t.co/Wx0T7RWukV pic.twitter.com/CvhWgTEwJb

— Intensive Care Medicine (@yourICM) April 14, 2022

 

---

Comentário | Solidão e saúde.

19 Abr, 2022 | 12:33h

Loneliness and health – Nature Reviews Disease Primers (se o acesso a este link for pago, tente este)

Conteúdos relacionados:

The prevalence of loneliness across 113 countries: systematic review and meta-analysis – The BMJ

Social Isolation and Loneliness – World Health Organization

Psychological Distress and Loneliness Reported by US Adults in 2018 and April 2020 – JAMA

Social isolation and loneliness as risk factors for myocardial infarction, stroke and mortality: UK Biobank cohort study of 479 054 men and women – Heart

 

Comentário no Twitter

In this Comment, Louise Hawkley discusses associations of #Loneliness with increased mortality and disease risk, and that a multi-level approach including individuals, community organizations and society is needed to reduce loneliness.@NORCNewshttps://t.co/CzP5fR6G0n pic.twitter.com/X3use2Aybe

— Nature Reviews Disease Primers (@DiseasePrimers) April 14, 2022

 

---

Estudo observacional em pacientes com doença renal crônica sugere que a quantidade ótima de ingestão de água é de cerca de 1 a 2 L/dia.

19 Abr, 2022 | 12:31h

Water intake and progression of chronic kidney disease: the CKD-REIN cohort study – Nephrology Dialysis Transplantation

---

Validação prospectiva de um teste rápido de expressão gênica do hospedeiro para diferenciar infecção respiratória bacteriana de viral.

19 Abr, 2022 | 12:20h

Prospective Validation of a Rapid Host Gene Expression Test to Discriminate Bacterial From Viral Respiratory Infection – JAMA Network Open

 

Comentário no Twitter

In this diagnostic study, a new host gene expression test identified patients unlikely to have bacterial infection in only 45 minutes, a potential new tool for antibiotic stewardship. https://t.co/3JiYl2N4b0

— JAMA Network Open (@JAMANetworkOpen) April 14, 2022

 

---

Estudo randomizado | Entre pacientes que aguardam por um artroplastia total de joelho com IMC acima de 35, a cirurgia bariátrica antes do procedimento foi associada com risco reduzido de complicações.

19 Abr, 2022 | 12:17h

Effect of Bariatric Surgery on Risk of Complications After Total Knee Arthroplasty: A Randomized Clinical Trial – JAMA Network Open

Comentário: Bariatric Surgery Before TKA Cuts Complications in Obese Patients – HealthDay

 

Comentário no Twitter

In this RCT, bariatric surgery before knee replacement (TKA) reduced the risk of complications in TKA in adults <65y with class II obesity scheduled to undergo TKA; 30% had sufficient symptom improvement to decline TKA altogether. https://t.co/qyhl0eIV2o

— JAMA Network Open (@JAMANetworkOpen) April 14, 2022

 

---

Risco de transmissão domiciliar assintomática de infecção por Clostridioides difficile associada com internação recente de membros da família.

19 Abr, 2022 | 12:13h

Risk for Asymptomatic Household Transmission of Clostridioides difficile Infection Associated with Recently Hospitalized Family Members – Emerging Infectious Diseases

Comentário: Recently Discharged Patients Pose Risk for Spreading C. Difficile Infection – HealthDay

---

Achado incidental de doença pulmonar intersticial: abordagem diagnóstica, vigilância e perspectivas.

19 Abr, 2022 | 12:10h

Incidental discovery of interstitial lung disease: diagnostic approach, surveillance and perspectives – European Respiratory Review

---

Covid-19: qual é a evidência para o uso do antiviral molnupiravir?

18 Abr, 2022 | 15:30h

Covid-19: What is the evidence for the antiviral molnupiravir? – The BMJ

---